Radiomics in PET/CT: Current Status and Future AI-Based Evolutions-Reference-Cited by-同舟云学术

Radiomics in PET/CT: Current Status and Future AI-Based Evolutions

Published:2021-03 Issue:2 Volume:51 Page:126-133
ISSN:0001-2998
Container-title:Seminars in Nuclear Medicine
language:en
Short-container-title:Seminars in Nuclear Medicine

Author:

Hatt Mathieu,Cheze Le Rest Catherine,Antonorsi Nils,Tixier Florent,Tankyevych Olena,Jaouen Vincent,Lucia Francois,Bourbonne Vincent,Schick Ulrike,Badic Bogdan,Visvikis Dimitris

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference95 articles.

1. A combined PET/CT scanner for clinical oncology;Beyer;J Nucl Med,2000

2. Innovations in instrumentation for positron emission tomography;Berg;Semin Nucl Med,2018

3. History and future technical innovation in positron emission tomography;Jones;J Med Imaging,2017

4. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors;Wahl;J Nucl Med,2009

5. What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis;Bonomo;Eur J Nucl Med Mol Imaging,2018

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SDH-related head and neck paragangliomas: Unraveling PET radiomics beyond 18F-FDG;Best Practice & Research Clinical Endocrinology & Metabolism;2024-08

2. Review on radiomic analysis in 18F-fluorodeoxyglucose positron emission tomography for prediction of melanoma outcomes;Cancer Imaging;2024-07-05

3. Associations between Radiomics and Genomics in Non-Small Cell Lung Cancer Utilizing Computed Tomography and Next-Generation Sequencing: An Exploratory Study;Genes;2024-06-18

4. Increased off-target binding of [18F]florbetaben in the skull of women with reduced skull density;Nuklearmedizin - NuclearMedicine;2024-02-22

5. [18F]FDG PET radiomics score generated by cross-combination approach for treatment response and prognosis prediction in primary gastrointestinal diffuse large B-cell lymphoma patients;2023-12-12